Volpara takeover by Lunit gets tick from Grant Samuel

Volpara takeover by Lunit gets tick from Grant Samuel
A technician uses Volpara's system to screen for breast cancer. (Image: Getty)
Pattrick Smellie
Directors in Wellington-headquartered health-tech firm Volpara are recommending shareholders accept a 100% takeover bid from a Korean-listed counterpart after a favourable independent valuation.ASX-listed Volpara was judged by independent valuer Grant Samuel to be worth between A67c (72c) and A82c per share, compared with the takeover from Seoul-based Lunit pitched at A$1.15.The offer represented a 47% premium to the A87cps that Volpara was trading at before the Lunit bid on Dec 14, and 55% above the weighted average share price in the month be...

More Markets

NZ sharemarket ends week up slightly
Markets Market close

NZ sharemarket ends week up slightly

The S&P/NZX 50 Index closed at 13,066.92, up 13.36 points or 0.10%.

Graham Skellern 29 Nov 2024
WasteCo reports loss as it seeks capital for acquisition
Markets

WasteCo reports loss as it seeks capital for acquisition

A week after WasteCo announced a conditional agreement to acquire Civic Waste and launched a share purchase plan proposal, the group posted a $5.5 million net loss. In earnings for the six months to Sept 30, released to the New Zealand Exchange (NZX) on Friday, WasteCo disclosed...

Staff reporters 29 Nov 2024
Fonterra forecasts highest NZ milk collections in four years
Primary Sector

Fonterra forecasts highest NZ milk collections in four years

More milk, higher payouts, could see $3 billion extra revenue in the economy.

Riley Kennedy 29 Nov 2024
Oh boy, Oboz: KMD Brands' limping footwear segment
Retail

Oh boy, Oboz: KMD Brands' limping footwear segment

 ‘It’s got a lot to iron out,’ Forsyth Barr’s Paul Koraua says.

Gregor Thompson 29 Nov 2024